Annual report pursuant to Section 13 and 15(d)

Statements of Cash Flows

Statements of Cash Flows
12 Months Ended
Sep. 30, 2018
USD ($)
Operating Activities  
Net loss $ (665,385)
Adjustments to reconcile net loss to net cash used in operating activities:  
Interest earned on cash and marketable securities held in Trust account (1,593,432)
Interest receivable on cash and marketable securities held in Trust account (221,157)
Change in operating assets and liabilities:  
Receivable from related party (6,229)
Prepaid expenses (110,439)
Accounts payable 64,581
Accrued liabilities 772,840
Other current liabilities 221,865
Net cash used in operating activities (1,537,356)
Investing Activities  
Investment of cash in trust account, net (143,750,000)
Cash withdrawn from trust account 379,123
Net cash used in investing activities (143,370,877)
Financing Activities  
Proceeds from sale of Units, net of underwriting discounts paid 141,162,440
Proceeds from sale of Private Placement Units 4,982,560
Proceeds from the sale of Founder Shares 25,000
Promissory notes from related parties 50,536
Repayment of promissory notes from related parties (50,536)
Payment of deferred offering costs (664,499)
Net cash provided by financing activities 145,505,501
Net change in cash and cash equivalents 597,268
Cash and cash equivalents, end of period 597,268
Supplemental disclosure of noncash investing activities  
Change in value of common stock subject to possible redemption $ (657,826)